NCT01093508View on ClinicalTrials.gov

Single-dose Safety Study of APD916 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

April 30, 2010

Study Completion Date

July 31, 2010

Conditions
Narcolepsy With or Without Cataplexy
Interventions
DRUG

APD916

Trial Locations (1)

45255

Community Research, Cincinnati

Sponsors
All Listed Sponsors
lead

Arena Pharmaceuticals

INDUSTRY

NCT01093508 - Single-dose Safety Study of APD916 in Healthy Volunteers | Biotech Hunter | Biotech Hunter